The collected and future blood samples

are to be analyzed for the following biological markers
at the respective laboratories:


1. selected plasma proteins Abbott, Chicago, IL, USA (Center of Excellence, Amsterdam)
2. serum cathepsin Institute of Pharmacology, University of Ljubljana,Slovenia
3. selected plasma proteins EDP Biosciences, Knoxville, TN, USA
4. tumor-derived DNA mutations Clinical Genomics, Bridgewater, NJ, USA
5. (◊) tumor-derived DNA methylations The Depart. of Molecular Medicine (MOMA), Skejby Hospital, University of Aarhus
 6. selected plasma proteins Fred Hutchinson Cancer Research Center, Seattle, WA, USA
 7. selected nucleosomes & histone modifications VolitionRX, Isnes, Belgium
 8. selected plasma proteins DiscernDX, San Francisco, CA, USA
 9. serum metabolomes ChemImage Inc., Pittsburgh, PA, USA
 10. plasma galectin-3 analytes MD Anderson Cancer Center, Houston, TX, USA
 11. serum YKL-40 Oncological Laboratory, Herlev Hospital
12. miRNA City of Hope Hospital, Pasadena, CA, USA

(◊)     This specific part of the entire project is sponsored by The Danish Strategic Research Council (19,9 mio. DKK)
in collaboration withThe Depart. of Molecular Medicine (MOMA), Skejby Hospital, Johns Hopkins Sidney Kimmel Cancer Center, Baltimore, MD, USA; and University College London.




Read more:






Our Research

Screening-research History

Print Friendly, PDF & Email


ColoRectal Cancer Research

Gastroenheden, Hvidovre Hospital

Kettegård Allé 30

2650 Hvidovre